Hypermethylation of growth Arrest DNA-damage-inducible gene 45 in non-small cell lung cancer and its relationship with clinicopathologic features

Elsevier BV - Tập 30 - Trang 89-92 - 2010
Yeon Kyung Na1, Su Man Lee1, Hae Sook Hong2, Jae Bum Kim3, Jae Yong Park4, Dong Sun Kim1
1Department of Anatomy, School of Medicine, Kyungpook National University, Daegu, Korea
2Colleage of Nursing, Kyungpook National University, Daegu, Korea
3School of Biological Sciences, Seoul National University, Seoul, Korea
4Internal Medicine, Kyungpook National University, Daegu, Korea

Tóm tắt

The growth arrest DNA-damage-inducible protein 45 (GADD45) can serve as a key coordinator of the stress response by regulating cell cycle progression, genomic stability, DNA repair, and other stress-related responses. Although deregulation of GADD45 expression has been reported in several types of human tumors, its role in lung cancer is still unknown. DNA hypermethylation of promoter CpG islands is known to be a major mechanism for epigenetic inactivation of tumor suppressor genes. We investigated the methylation status of GADD45 family genes (GADD45A, B, and G) in 139 patients with non-small cell lung cancer (NSCLC) using methylation-specific PCR (MSP) and correlated the results with clinicopathologic features of the patients. Methylation frequencies in tumors were 1.4% for GADD45A, 7.2% for GADD45B, and 31.6% for GADD45G. RT-PCR and MSP analysis showed that promoter methylation of the GADD45G gene resulted in downregulation of its mRNA expression. GADD45G methylation was significantly more frequent in female patients than male patients (P = 0.035). This finding suggests that methylation-associated down-regulation of the GADD45G gene may be involved in lung tumorigenesis.

Tài liệu tham khảo

Baylin, S.B., and Herman, J.G. (2000). DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16, 168–174. Belinsky, S.A. (2004). Gene-promoter hypermethylation as a biomarker in lung cancer. Nat. Rev. Cancer 4, 1–11. Cretu, A., Sha, X., Tront, J., Hoffman, B., and Liebermann, D.A. (2009). Stress sensor Gadd45 genes as therapeutics targets in cancer. Cancer Ther. 7, 268–276. Guillouf, C., Grana, X., Selvakumaran, M., Hoffman, B., Giordano, A., and Liebermann, D.A. (1995). Dissection of the genetic programs of p53 G1 growth arrest and apoptosis: blocking p53-induced apoptosis unmasks G1 arrest. Blood 85, 2691–2698. Hoffman, B., and Liebermann, D.A. (2008). Gadd45 in stress signaling. J. Mol. Signal. 3, 15. Hollander, M.C., Sheikh, M.S., Bulavin, D.V., Lundgren, K., Augeri-Henmueller, L., Shehee, R., Molinaro, T.A., Kim, K.E., Tolosa, E., Ashwell, J.D. et al. (1999). Genomic instability in Gadd45adeficient mice. Nat. Genet. 23, 176–184. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., and Thun, M.J. (2008). Cancer statistics, 2008. CA Cancer J. Clin. 58, 71–96. Jones, P.A., and Baylin, S.B. (2002). The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415–428. Kim, D.S., Kim, M.J., Lee, J.Y., Lee, S.M., Choi, J.E., Lee, S.Y., and Park, J.Y. (2009). Epigenetic inactivation of checkpoint kinase 2 gene in non-small cell lung cancer and its relationship with clinicopathological features. Lung Cancer 65, 247–250. Qui, W., Zhou, B., Zou, H., Liu, X., Chu, P.G., Lopez, R., Shih, J., Chung, C., and Yen, Y. (2004). Hyperemthylation of growth arrest and DNA damage-inducible gene 45 promoter in human hepatocellular carcinoma. Am. J. Pathol. 165, 1689–1699. Safar, A.M., Spencer, H. 3rd, Su, X., Coffey, M., Cooney, C.A., Ratnasinghe, L.D., Hutchins, L.F., and Fan, C.Y. (2005). Methylation profiling of archived non-small cell lung cancer: a promising prognostic system. Clin. Cancer Res. 11, 4400–4405. Schulz, W.A., Alexa, A., Jung, V., Hader, C., Hoffmann, M.J., Yamanaka, M., Fritzsche, S., Wlazlinski, A., Muller, M., Lengauer, T., et al. (2007). Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer. Mol. Cancer 6, 14. Shaulian, E., and Karin, M. (1999) Stress-induced JNK activation is independent of Gadd45 induction. J. Biol. Chem. 274, 29595–29598. Sidransky, D. (2002). Emerging molecular markers of cancer. Nat. Rev. Cancer 2, 210–219. Tront, J.S., Hoffman, B., and Liebermann, D.A. (2006). Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of JNK and p38 stress signaling resulting in apoptosis and senescence. Cancer Res. 66, 8448–8854. Tsou, J.A., Hagen, J.A., Carpenter, C.L., and Laird-Offringa, I.A. (2002). DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene 21, 5450–5461. Ying, J., Srivastava, G., Hsieh, W.S., Gao, Z., Murray, P., Liao, S.K., Ambinder, R., and Tao, Q. (2005). The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin. Cancer Res. 11, 6442–6449. Yoo, J., Ghiassi, M., Jirmanova, L., Balliet, A.G., Hoffman, B., Fornace, A.J. Jr, Liebernann, D.A., Bottinger, E.P., and Roberts, A.B. (2003). TGF-β-induced apoptosis is mediated by Smad-dependent expression of GADD45B through p38 activation. J. Biol. Chem. 278, 43001–43007. Zhang, W., Bae, I., Krishnaraju, K., Azam, N., Fan, W., Smith, K., Hoffman, B., and Liebernann, D.A. (1999). CR6: a third member in the MyD118 and Gadd 45 gene family which functions in negative growth control. Oncogene 18, 4899–4907.